Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor- Positive Endometrial Cancer

The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial cancers that overexpress folate receptor alpha (FR).

uterine papillary serous carcinoma
carcinosarcoma
imgn853
cancer
endometrial adenocarcinoma
  • 0 views
  • 16 Aug, 2021
  • 1 location
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

This phase II trial studies the side effects of ONC201 and paclitaxel and how well they work in treating patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent), or that does not respond to treatment (refractory). ONC201 is the first in its class …

  • 0 views
  • 11 Jul, 2021
  • 1 location
The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate

University Hospital (NTUH). Some cytokines that will be measured include vasculoendothelial growth factor, hyaluronan, transforming growth factor-β, procollagen, and cancer antigen-125. The same

  • 0 views
  • 07 Nov, 2020